Capital One Just Flashed a Buy Signal—New Highs Could Be Next — Positive

COF   MarketBeat — October 23, 2025

The company delivered a stellar earnings report. Based on the stock price and analyst reaction immediately following the report, it's a good time to buy the financial services company's stock.

image for news Capital One Just Flashed a Buy Signal—New Highs Could Be Next

WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit — Positive

WST   Zacks Investment Research — October 23, 2025

West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.

image for news WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit

As Renewables Eclipse Coal, Is it Time to Invest in Clean Energy ETFs? — Neutral

ACES  ICLN  PBW  QCLN   Zacks Investment Research — October 23, 2025

Renewables have overtaken coal in global power generation, putting clean energy ETFs like ICLN, QCLN and PBW in sharp investor focus.

image for news As Renewables Eclipse Coal, Is it Time to Invest in Clean Energy ETFs?

Valero Energy Q3 Earnings Beat Estimates on Higher Refining Margins — Positive

VLO   Zacks Investment Research — October 23, 2025

VLO posts a strong Q3 earnings beat as higher refining and ethanol margins offset weaker renewable diesel sales.

image for news Valero Energy Q3 Earnings Beat Estimates on Higher Refining Margins

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP reminds investors of the upcoming December 8, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired aTyr Pharma Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, inclusive (the “Class Period”). IF YOU SUFFERED A LOSS ON YOUR ATYR INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO.

image for news Deadline Alert: aTyr Pharma Inc. (ATYR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

George Gianarikas, managing director at Canaccord Genuity, joins CNBC's 'The Exchange' to discuss his reaction to Tesla's most recent quarter.

image for news Canaccord Genuity's Gianarikas: Tesla results increased conviction, but cautiousness remains

Sonic Automotive, Inc. (SAH) Q3 2025 Earnings Call Transcript — Neutral

SAH   Seeking Alpha — October 23, 2025

Sonic Automotive, Inc. (NYSE:SAH ) Q3 2025 Earnings Call October 23, 2025 11:00 AM EDT Company Participants David Smith - CEO & Chairman Frank Dyke - President & Director Heath R. Byrd - Executive VP & CFO Danny Wieland - Vice President of Investor Relations & Financial Reporting Conference Call Participants Jeffrey Lick - Stephens Inc., Research Division Michael Ward - Citigroup Inc., Research Division Rajat Gupta - JPMorgan Chase & Co, Research Division Patrick Buckley - Jefferies LLC, Research Division Christopher Pierce - Needham & Company, LLC, Research Division Michael Albanese - The Benchmark Company, LLC, Research Division Presentation …

image for news Sonic Automotive, Inc. (SAH) Q3 2025 Earnings Call Transcript

Third Coast Bancshares, Inc. (TCBX) Q3 2025 Earnings Call Transcript — Neutral

TCBX   Seeking Alpha — October 23, 2025

Third Coast Bancshares, Inc. (NYSE:TCBX ) Q3 2025 Earnings Call October 23, 2025 11:00 AM EDT Company Participants Bart Caraway - Founder, Chairman, President & CEO John McWhorter - Senior EVP & CFO Audrey Duncan - Senior EVP & Chief Credit Officer Conference Call Participants Natalie Hairston - Dennard Lascar Associates, LLC Bernard Von Gizycki - Deutsche Bank AG, Research Division Wood Lay - Keefe, Bruyette, & Woods, Inc., Research Division Michael Rose - Raymond James & Associates, Inc., Research Division Matt Olney - Stephens Inc. David Storms - Stonegate Capital Partners, Inc., Research Division Presentation Operator Greetings, and welcome …

image for news Third Coast Bancshares, Inc. (TCBX) Q3 2025 Earnings Call Transcript

QCR Holdings, Inc. (QCRH) Q3 2025 Earnings Call Transcript — Neutral

QCRH   Seeking Alpha — October 23, 2025

QCR Holdings, Inc. (NASDAQ:QCRH ) Q3 2025 Earnings Call October 23, 2025 11:00 AM EDT Company Participants Todd Gipple - President, CEO & Director Nick Anderson - Chief Financial Officer Conference Call Participants Damon Del Monte - Keefe, Bruyette, & Woods, Inc., Research Division Nathan Race - Piper Sandler & Co., Research Division Daniel Tamayo - Raymond James & Associates, Inc., Research Division Jeff Rulis - D.A. Davidson & Co., Research Division Brian Martin - Janney Montgomery Scott LLC, Research Division Presentation Operator Good morning, and thank you for joining us today for QCR Holdings, Inc. Third Quarter 2025 Earnings …

image for news QCR Holdings, Inc. (QCRH) Q3 2025 Earnings Call Transcript

TechnipFMC plc (FTI) Q3 2025 Earnings Call Transcript — Neutral

FTI   Seeking Alpha — October 23, 2025

TechnipFMC plc (NYSE:FTI ) Q3 2025 Earnings Call October 23, 2025 8:30 AM EDT Company Participants Matt Seinsheimer - Senior Vice President of Investor Relations & Corporate Development Douglas Pferdehirt - CEO & Executive Chairman Alf Melin - Executive VP & CFO Conference Call Participants Scott Gruber - Citigroup Inc., Research Division Victoria McCulloch - RBC Capital Markets, Research Division John Anderson - Barclays Bank PLC, Research Division Arun Jayaram - JPMorgan Chase & Co, Research Division Derek Podhaizer - Piper Sandler & Co., Research Division Ati Modak - Goldman Sachs Group, Inc., Research Division Sebastian Erskine - Rothschild & …

image for news TechnipFMC plc (FTI) Q3 2025 Earnings Call Transcript

Will Lower Patient Days Affect Tenet Healthcare's Q3 Earnings? — Negative

THC   Zacks Investment Research — October 23, 2025

THC's third-quarter results may show profit growth despite lower patient days and mixed hospital trends.

image for news Will Lower Patient Days Affect Tenet Healthcare's Q3 Earnings?

Here is Why Growth Investors Should Buy Royal Bank (RY) Now — Positive

RY   Zacks Investment Research — October 23, 2025

Royal Bank (RY) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news Here is Why Growth Investors Should Buy Royal Bank (RY) Now

3 Reasons Growth Investors Will Love Postal Realty Trust (PSTL) — Positive

PSTL   Zacks Investment Research — October 23, 2025

Postal Realty Trust (PSTL) could produce exceptional returns because of its solid growth attributes.

image for news 3 Reasons Growth Investors Will Love Postal Realty Trust (PSTL)

3 Reasons Why Growth Investors Shouldn't Overlook Neurocrine (NBIX) — Positive

NBIX   Zacks Investment Research — October 23, 2025

Neurocrine (NBIX) possesses solid growth attributes, which could help it handily outperform the market.

image for news 3 Reasons Why Growth Investors Shouldn't Overlook Neurocrine (NBIX)

3 Reasons Growth Investors Will Love Valmont (VMI) — Positive

VMI   Zacks Investment Research — October 23, 2025

Valmont (VMI) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news 3 Reasons Growth Investors Will Love Valmont (VMI)

3 Reasons Why NRG (NRG) Is a Great Growth Stock — Positive

NRG   Zacks Investment Research — October 23, 2025

NRG (NRG) could produce exceptional returns because of its solid growth attributes.

image for news 3 Reasons Why NRG (NRG) Is a Great Growth Stock

Fair Isaac (FICO) is an Incredible Growth Stock: 3 Reasons Why — Positive

FICO   Zacks Investment Research — October 23, 2025

Fair Isaac (FICO) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news Fair Isaac (FICO) is an Incredible Growth Stock: 3 Reasons Why

Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why — Positive

BSX   Zacks Investment Research — October 23, 2025

Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why

Is Celestica (CLS) a Solid Growth Stock? 3 Reasons to Think "Yes" — Positive

CLS   Zacks Investment Research — October 23, 2025

Celestica (CLS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

image for news Is Celestica (CLS) a Solid Growth Stock? 3 Reasons to Think "Yes"

Looking for a Growth Stock? 3 Reasons Why Vertiv (VRT) is a Solid Choice — Positive

VRT   Zacks Investment Research — October 23, 2025

Vertiv (VRT) could produce exceptional returns because of its solid growth attributes.

image for news Looking for a Growth Stock? 3 Reasons Why Vertiv (VRT) is a Solid Choice